Atlas Trials

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

Clinical trial NCT01482013 · TERMINATED

Trial details

NCT number
NCT01482013
Sponsor
High Point Pharmaceuticals, LLC.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Mild Alzheimer's DiseaseMild Cognitive Impairment
Start date
2011-10-01
Primary completion
2012-03-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.